Physician profile
Peter J Accetta
NPI 1912961467
$45,493.61
in general payments reported to CMS, 2019-2025
15 companies · $7,129 in 2025
The $7,129 reported for 2025 was more than what 91% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $126 · 2021: $8,349 · 2022: $10K · 2023: $10K · 2024: $8,733 · 2025: $7,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Food and Beverage: $86.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,087.00 |
| Food and Beverage | $86.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $24,197.79 | 2023-2025 | |
| Allergan, INC. | $20,872.88 | 2019-2023 | |
| Sandoz INC. | $90.05 | 2019-2020 | |
| Dermavant Sciences, INC. | $73.16 | 2023-2024 | Vtama |
| Leo Pharma INC. | $57.09 | 2019-2020 | |
| Dermira, INC. | $37.33 | 2019 | |
| Abbott Laboratories | $35.26 | 2022 | |
| Sun Pharmaceutical Industries INC. | $20.88 | 2020 | |
| Biofrontera INC. | $20.59 | 2019 | |
| Dusa Pharmaceuticals, INC. | $20.39 | 2019 | |
| Mayne Pharma Commercial LLC | $19.25 | 2019 | |
| Genentech USA, INC. | $13.52 | 2019 | |
| Pfizer INC. | $13.29 | 2019 | |
| Merck Sharp & Dohme LLC | $11.81 | 2019 | |
| Prugen, INC. Pharmaceuticals | $10.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Accetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.